Cargando…
Reviewing 15 years of experience with sirolimus
Here, we review 15 years of clinical use of sirolimus in our transplant center, in context with the developing immunosuppressive strategies use worldwide. The majority of studies were conducted in de novo kidney transplant recipients, using sirolimus (SRL) in combination with calcineurin inhibitors...
Autores principales: | Tedesco Silva, Helio, Rosso Felipe, Claudia, Medina Pestana, Jose Osmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895289/ https://www.ncbi.nlm.nih.gov/pubmed/27293553 http://dx.doi.org/10.1186/s13737-015-0028-6 |
Ejemplares similares
-
Early Hospital Readmission (EHR) in kidney transplantation: a review article
por: Tavares, Melissa Gaspar, et al.
Publicado: (2020) -
Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals
por: de Sandes-Freitas, Tainá Veras, et al.
Publicado: (2015) -
Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy
por: Oliveira, Lilian Caroline Gonçalves, et al.
Publicado: (2021) -
Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy
por: Bonezi, Vivian, et al.
Publicado: (2020) -
Predictors of mortality in renal transplant recipients with severe sepsis and septic shock
por: de Carvalho, Mônica Andrade, et al.
Publicado: (2013)